Atorvastatin Calcium
Product Images NDC 68071-4798

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-4798). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 4798 3)

The image shows a NuCare Pharmaceuticals, Inc. packaging label for Atorvastatin Calcium 40 mg tablets. The label specifies a quantity of 30 tablets with product number P1916030. It notes that each film-coated tablet contains atorvastatin calcium equivalent to 40 mg of atorvastatin. The tablets are described as oval, white, and engraved with 'APO' on one side and 'ATV40' on the other. The label includes NDC 68071-4798-3 and storage instructions to keep at controlled temperatures between 59-86°F. The label includes warnings to keep out of reach of children and states Rx Only.*

FDA Label Image

Figure-01 (Figure 01)

A line graph comparing cumulative incidence (%) over time (years) between Atorvastatin and Placebo groups. The graph shows two lines: a solid line for Atorvastatin with lower cumulative incidence, and a dashed line for Placebo with higher values. Statistical data at the bottom right includes a hazard ratio (HR=0.64 [0.50-0.83]) and a p-value (0.0005).*

FDA Label Image

Figure-02 (Figure 02)

A line graph showing cumulative hazard percentage over time (years) comparing Atorvastatin and placebo. The graph illustrates time to first primary endpoint through four years of follow-up, with Atorvastatin showing lower cumulative hazard than placebo. Hazard ratio (HR) and p-value are indicated on the graph.*

FDA Label Image

Figure-03 (Figure 03)

A line graph depicting cumulative subjects (%) experiencing an event over time (years) for Atorvastatin 10 mg and 80 mg doses. The x-axis shows time to first major cardiovascular endpoint from 0 to 5 years, and the y-axis shows the percentage of subjects experiencing the event from 0.0 to 0.2%. The graph includes hazard ratio and p-value for comparison between doses.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure diagram of Atorvastatin Calcium, showing the molecular components including calcium ions and associated organic groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.